Evidence map›Paper›PMID 32423387›Full record

ArticleBMC nephrology2020

Glomerulonephritis Histopathological Pattern Change.

Anas AlYousef, Ali AlSahow, Bassam AlHelal, Ahmed Alqallaf, Emad Abdallah, Mohammed Abdellatif, Hani Nawar, Riham Elmahalawy

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06835322 (Effect of Finerenone on Proteinuria and GFR Progression in Patients With Non Diabetic Glomerulonephritis), which is not on this map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06835322 phase2completednot on this mapstarted 2025, after this paper: background citation

Effect of Finerenone on Proteinuria and GFR Progression in Patients With Non Diabetic Glomerulonephritis: A Randomized Clinical Trial

TypeinterventionalSponsorAlexandria UniversityRan2025 to 2026Enrolled100ConditionsGlomerulonephritisArmsFinerenone, Placebo
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Drug-related proteinuria: a vigilance analysis based on the FAERS database.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Inflammation in glomerular diseases.Frontiers in immunology · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Anas AlYousefFarwaniya Hospital, Department of Internal Medicine, Nephrology Unit, Sabah Al Nasser, Kuwait. Anas.alyousef@gmail.com.ORCID 0000-0002-5450-8083
Ali AlSahowAl Jahra Hospital, Department of Internal Medicine, Nephrology Unit, Al Jahra, Kuwait.
Bassam AlHelalAl Adan Hospital, Department of Internal Medicine, Nephrology Unit, Hadiya, Kuwait.
Ahmed AlqallafMubarak Al-Kabeer Hospital, Department of Internal Medicine, Nephrology Unit, Jabriya, Kuwait.
Emad AbdallahAl Adan Hospital, Department of Internal Medicine, Nephrology Unit, Hadiya, Kuwait.
Mohammed AbdellatifFarwaniya Hospital, Department of Internal Medicine, Nephrology Unit, Sabah Al Nasser, Kuwait.
Hani NawarAl Jahra Hospital, Department of Internal Medicine, Nephrology Unit, Al Jahra, Kuwait.
Riham ElmahalawyMubarak Al-Kabeer Hospital, Department of Internal Medicine, Nephrology Unit, Jabriya, Kuwait.
Adan Hospital · KWFarwaniya Hospital · KWJahra Hospital · KWMubarak Al Kabeer Hospital · KW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlomerulonephritides (GN) are relatively rare kidney diseases with substantial morbidity and mortality. They are often difficult to treat, sometimes with no cure, and can lead to chronic kidney disease (CKD) and end stage kidney disease (ESKD). Kidney biopsy is the diagnostic procedure of choice with variable indications from center to center. It helps in identifying the exact specific diagnosis, assessing the level of disease activity and severity, and hence aids in proper therapy and helps predicting prognosis. There is a global change of pattern of glomerular disease over the last five decades.

methodsRetrospective analysis of all kidney biopsies (545 cases) that were done in patients over 12 year-old over last six years in four major hospitals in Kuwait. The indications for kidney biopsy were categorized into six clinical syndromes: nephrotic syndrome, sub-nephrotic proteinuria, nephrotic syndrome plus acute kidney injury (AKI), sub-nephrotic proteinuria plus AKI, isolated hematuria, and Unexplained renal impairment. We calculated the incidence of each type of kidney disease and indication of biopsy.

resultsmost common indication of kidney biopsy was sub-nephrotic proteinuria associated with AKI in 179 cases (32.8%). Primary Glomerulonephritis was the main diagnosis that was reported in 356 cases (65.3%). Immunoglobulin A Nephropathy (IgAN) was the commonest lesion in primary glomerulonephritis in 85 (23.9%) cases. Secondary Glomerulonephritis was diagnosed in 134 cases (24.6%), 56 (41.8%) of them were reported as lupus nephritis cases. In young adults (below 18 years of age) there were 31 cases reviews, 35.5% were found to have minimal change disease (MCD).

conclusionIgAN is the commonest glomerulonephritis in primary nephrotic syndromes in Kuwait over the past six years. Lupus nephritis is the leading secondary glomerulonephritis diagnosis.

Indexed as

Acute Kidney InjuryAdolescentAdultAgedAged, 80 and overAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisChildDiabetic NephropathiesFemaleGlomerulonephritisGlomerulonephritis, IGAGlomerulonephritis, MembranousGlomerulosclerosis, Focal SegmentalHematuriaHumansKuwaitDiabetic Kidney DiseaseGlomerulonephritisIgA NephropathyKidney Biopsy Nephrotic Syndrome

Identifiers

PMID32423387
PMCPMC7236312
OpenAlexW3028362203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.